HomeCompareSBTX vs NNN

SBTX vs NNN: Dividend Comparison 2026

SBTX yields 34.07% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBTX wins by $141.5K in total portfolio value
10 years
SBTX
SBTX
● Live price
34.07%
Share price
$5.87
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$24,647.82
Full SBTX calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — SBTX vs NNN

📍 SBTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSBTXNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SBTX + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SBTX pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBTX
Annual income on $10K today (after 15% tax)
$2,896.08/yr
After 10yr DRIP, annual income (after tax)
$20,950.65/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, SBTX beats the other by $18,721.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBTX + NNN for your $10,000?

SBTX: 50%NNN: 50%
100% NNN50/50100% SBTX
Portfolio after 10yr
$96.2K
Annual income
$13,635.25/yr
Blended yield
14.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

SBTX
Analyst Ratings
5
Hold
Consensus: Hold
Altman Z
-0.3
Piotroski
1/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBTX buys
0
NNN buys
0
No recent congressional trades found for SBTX or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSBTXNNN
Forward yield34.07%5.66%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$167.0K$25.5K
Annual income after 10y$24,647.82$2,622.67
Total dividends collected$119.3K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold

Year-by-year: SBTX vs NNN ($10,000, DRIP)

YearSBTX PortfolioSBTX Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$14,107$3,407.16$10,735$614.96+$3.4KSBTX
2$19,587$4,492.08$11,572$708.43+$8.0KSBTX
3$26,787$5,828.90$12,531$819.53+$14.3KSBTX
4$36,112$7,450.06$13,633$952.29+$22.5KSBTX
5$48,026$9,386.56$14,909$1,111.84+$33.1KSBTX
6$63,055$11,666.79$16,392$1,304.77+$46.7KSBTX
7$81,784$14,315.54$18,129$1,539.52+$63.7KSBTX
8$104,862$17,353.02$20,173$1,827.08+$84.7KSBTX
9$132,997$20,794.11$22,597$2,181.81+$110.4KSBTX
10$166,954$24,647.82$25,491$2,622.67+$141.5KSBTX

SBTX vs NNN: Complete Analysis 2026

SBTXStock

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Full SBTX Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this SBTX vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBTX vs SCHDSBTX vs JEPISBTX vs OSBTX vs KOSBTX vs MAINSBTX vs ADCSBTX vs EPRTSBTX vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.